Radiotherapy for primary thyroid cancer as a risk factor for second primary cancers

Cancer Letters

Volumn 238, Issue 1, 2006, Pages 42-52

  Chuang, Shu Chun ^a   Hashibe, Mia ^b   Yu, Guo Pei ^c   Le, Anh D ^d   Cao, Wei ^a   Hurwitz, Eric L ^a   Rao, Jian Yu ^e   Neugut, Alfred I ^f   Zhang, Zuo Feng ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c NEW YORK EYE AND EAR INFIRMARY   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f Columbia University ^*  (United States)

Author keywords

Radiation therapy; Second cancer; Thyroid cancer

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; DISEASE ASSOCIATION; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; GYNECOLOGIC CANCER; HEAD AND NECK CANCER; HUMAN; KIDNEY CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MALE GENITAL TRACT CANCER; METASTASIS; MYELOID LEUKEMIA; PRIORITY JOURNAL; RADIATION HAZARD; RESPIRATORY TRACT TUMOR; RISK ASSESSMENT; RISK FACTOR; THYROID CANCER;

AGED; AGED, 80 AND OVER; CAUSALITY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; RADIOTHERAPY; RISK ASSESSMENT; RISK FACTORS; SEER PROGRAM; THYROID NEOPLASMS; TIME; UNITED STATES;

EID: 33744927671     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.06.015     Document Type: Article

References (28)

1. Manavoglu O., Orhan B., Evrensel T., Karabulut Y., Ozkocaman V., and Ozyardimci C. Second primary cancer due to radiotherapy and chemotherapy. J. Environ. Pathol. Toxicol. Oncol. 15 (1996) 275-278
2. IARC Working group on the evaluation of carcinogenic risks to humans: ionizing radiation, Part I, X- and gamma- radiation and neutrons, Lyon, France, 26 May-2 June 1999, IARC Monogr Eval. Carcinog. Risks Hum. 75, Pt 1, 2000, p. 1-448
3. Gorges R. The Changing Epidemiology of Thyroid Cancer (2001), Springer, Berlin, Heidelberg 3-25
4. Pierie J.P., Muzikansky A., Gaz R.D., Faquin W.C., and Ott M.J. The effect of surgery and radiotherapy on outcome of anaplastic thyroid carcinoma. Ann. Surg. Oncol 9 (2002) 57-64
5. Surveillance, Epidemiology, and End Results (SEER) Program Public-Use Data (1973-2000), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Review Branch, released April 2003, based on the November 2002 submission, 2004.
6. M.a.L.J.D.G.M. Furio Pacini, Thyroid neoplasia, in: M. Nobuyuki Amino, M. Paolo Beck-Peccoz, M. Manfred Blum, The thyroid and its disease, 4 A.D.
7. Hegedus L. Clinical practice. The thyroid nodule. N. Engl. J. Med. 351 (2004) 1764-1771
8. Evans T.C. Thyroid disease. Prim. Care 30 (2003) 625-640
9. Lamonica D. Iodine 131 ((131)I) as adjuvant therapy of differentiated thyroid cancer. Surg. Oncol. Clin. N. Am. 13 (2004) 129-149
10. Kinder B.K. Well differentiated thyroid cancer. Curr. Opin. Oncol. 15 (2003) 71-77
11. Parthasarathy K.L., and Crawford E.S. Treatment of thyroid carcinoma: emphasis on high-dose 131I outpatient therapy. J. Nucl. Med. Technol. 30 (2002) 165-171
12. Figge J J.T.G.G. Radiation and Thyroid Cancer (2000) 85-119
13. Hall P., Holm L.E., and Lundell G. Second primary tumors following thyroid cancer. A Swedish record-linkage study. Acta Oncol. 29 (1990) 869-873
14. Van Leeuven FE T.L. Second cancers. In: Devita V.T. (Ed). Cancer: Principles and Practice of Oncology (2001), Lippinocott Williams and WilkinsLippincott Williams and Wilkins, Philadelphia 2939-2964
15. S.A.V.P.T.M. Van Leeuwen FE, Second cancers after treatment of Hodgkins's disease, in: A.J.D.V.H.R.W.L. Mauch PM,. (Eds.), Hodgkin's disease,, Lippincott Williams & Wilkins, Philadelphia, 1999, pp. 607-632
16. The SEER program code manual, third edition, National Cancer Institute, DCCPS, Cancer Surveillance Research Program, Cancer Statistics Branch, 1998, 2004.
17. Schlumberger M., Parmentier C., De Vathaire F., and Tubiana M. Iodine-131 and external radiation in the treatment of local and metastatic thyroid cancer. In: Falk S.A. (Ed). Thyroid Disease: Endocrinology, Surgery, Neclear Medicine, and Radiotherapy (1997), Lippincott-Raven, Philadelphia 601-617
18. Hyer S., Vini L., O'Connell M., Pratt B., and Harmer C. Testicular dose and fertility in men following I(131) therapy for thyroid cancer. Clin. Endocrinol. (Oxf) 56 (2002) 755-758
19. Hall P., Holm L.E., Lundell G., Bjelkengren G., Larsson L.G., Lindberg S., Tennvall J., Wicklund H., Boice Jr. J.D., et al. Cancer risks in thyroid cancer patients. Br. J. Cancer 64 (1991) 159-163
20. Johns M.E., Shikhani A.H., Kashima H.K., and Matanoski G.M. Multiple primary neoplasms in patients with salivary gland or thyroid gland tumors. Laryngoscope 96 (1986) 718-721
21. Ron E., Curtis R., Hoffman D.A., and Flannery J.T. Multiple primary breast and thyroid cancer. Br. J. Cancer 49 (1984) 87-92
22. Vassilopoulou-Sellin R., Palmer L., Taylor S., and Cooksley C.S. Incidence of breast carcinoma in women with thyroid carcinoma. Cancer 85 (1999) 696-705
23. Chen A.Y., Levy L., Goepfert H., Brown B.W., Spitz M.R., and Vassilopoulou-Sellin R. The development of breast carcinoma in women with thyroid carcinoma. Cancer 92 (2001) 225-231
24. Ron E., Lubin J.H., Shore R.E., Mabuchi K., Modan B., Pottern L.M., Schneider A.B., Tucker M.A., Boice Jr. J.D., et al. Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat. Res. 141 (1995) 259-277
25. Moysich K.B., Menezes R.J., and Michalek A.M. Chernobyl-related ionising radiation exposure and cancer risk: an epidemiological review. Lancet Oncol. 3 (2002) 269-279
26. Rubino C., Cailleux A.F., De Vathaire F., and Schlumberger M. Thyroid cancer after radiation exposure. Eur. J. Cancer 38 (2002) 645-647
27. Penn I. Second neoplasms following radiotherapy or chemotherapy for cancer. Am. J. Clin. Oncol. 5 (1982) 83-96
28. H. Pastides, Ionizing, nonionizing, and solar radiation and cancer, (2001) 207-219